Gene · 6839
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-Lasting Epigenetic Changes in the Dopamine Transporter in Adult Animals Exposed to Amphetamine during Embryogenesis: Investigating Behavioral Effects. | Int J Mol Sci | 2023 | 37685899 | PubTator, text mining | PubMed |
| SUMO1-regulated DBC1 promotes p53-dependent stress-induced apoptosis of lens epithelial cells. | Aging (Albany NY) | 2023 | 37683133 | PubTator, text mining | PubMed |
| Whole exome sequencing highlights rare variants in CTCF, DNMT1, DNMT3A, EZH2 and SUV39H1 as associated with FSHD. | Front Genet | 2023 | 37674478 | PubTator, text mining | PubMed |
| Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and disease. | Front Genet | 2023 | 37671044 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| Transposable elements as tissue-specific enhancers in cancers of endodermal lineage. | Nat Commun | 2023 | 37658059 | PubTator, text mining | PubMed |
| Cellular and molecular waypoints along the path of T cell exhaustion. | Sci Immunol | 2023 | 37656775 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis. | Sci Rep | 2023 | 37648722 | PubTator, text mining | PubMed |
| Sex-biased genome-editing effects of CRISPR-Cas9 across cancer cells dependent on p53 status. | iScience | 2023 | 37636042 | PubTator, text mining | PubMed |
| Histone Modification of Colorectal Cancer by Natural Products. | Pharmaceuticals (Basel) | 2023 | 37631010 | PubTator, text mining | PubMed |
| Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins. | Int J Mol Sci | 2023 | 37629054 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| 27-Hydroxycholesterol represses G9a expression via oestrogen receptor alpha in breast cancer. | J Cell Mol Med | 2023 | 37614064 | PubTator, text mining | PubMed |
| RepID represses megakaryocytic differentiation by recruiting CRL4A-JARID1A at DAB2 promoter. | Cell Commun Signal | 2023 | 37612584 | PubTator, text mining | PubMed |
| Histidine N1-position-specific methyltransferase CARNMT1 targets C3H zinc finger proteins and modulates RNA metabolism. | Genes Dev | 2023 | 37612136 | PubTator, text mining | PubMed |
| RNF4 and USP7 cooperate in ubiquitin-regulated steps of DNA replication. | Open Biol | 2023 | 37607592 | PubTator, text mining | PubMed |
| The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma. | Open Life Sci | 2023 | 37588995 | PubTator, text mining | PubMed |
| SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. | JCI Insight | 2023 | 37581938 | PubTator, text mining | PubMed |
| Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review. | J Clin Transl Hepatol | 2023 | 37577231 | PubTator, text mining | PubMed |
| In Vivo Identification of H3K9me2/H3K79me3 as an Epigenetic Barrier to Carcinogenesis. | Int J Mol Sci | 2023 | 37569534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/papers?page=12